Close Menu

NEW YORK – Cancer Genetics reported on Monday that its fourth quarter revenues grew about 12 percent year over year, which the firm noted was  partially the result of the adoption of the new ASC 606 revenue recognition standard and the variability in project start and end times at the individual contract level in the firm's discovery services business unit.

For the three months ended Dec. 31, 2019, the firm reported total revenues from continuing operations of $1.9 million, up from $1.7 million in the fourth quarter of 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.